Sorcha Eastwood MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
16 published records · newest first.
Written questions
Medical Treatments: StandardsDepartment of Health and Social CareTabled 2 Jul 2026AnsweredUIN 15545More
Question: To ask the Secretary of State for Health and Social Care, when the EQ-5D-5L quality of life value set will be adopted in NICE technology appraisals.
Answer: The National Institute for Health and Care Excellence (NICE) is planning to adopt the EQ-5D-5L value set and has recently consulted on proposed changes to its guidance development manuals. NICE is now considering the responses to the consultation and expe...
Answered 8 Jul 2026
Original Parliament recordAllergies: Medical TreatmentsDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3540More
Question: To ask the Secretary of State for Health and Social Care, what discussions his Department has had with NICE on the introduction of EURneffy for use in the emergency treatment of serious allergies.
Answer: Following the approval of an adrenaline nasal spray by the Medicines and Healthcare products Regulatory Agency (MHRA) in July 2025, the Government is considering whether any amendments to Schedule 17 of the Human Medicines Regulations 2012 are appropriate...
Answered 1 Jun 2026
Original Parliament recordCancer: ChildrenDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110553More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with the Northern Ireland Department of Health and the Northern Ireland Executive to ensure that families of children and young people with cancer in Northern Ireland ca
Answer: The Department knows that the cost of travel is an important issue for many young cancer patients and their families across the United Kingdom.Through the National Cancer Plan, the Government is committing up to £10 million a year to a new fund open to al...
Answered 10 Feb 2026
Original Parliament recordPublic Expenditure: Northern IrelandDepartment of Health and Social CareTabled 3 Feb 2026AnsweredUIN 110552More
Question: To ask the Secretary of State for Health and Social Care, what Barnett consequentials arise for Northern Ireland as a result of the £10 million per year funding announced to cover travel costs for children and young people with cancer in England.
Answer: The Department knows that the cost of travel is an important issue for many young cancer patients and their families across the United Kingdom.Through the National Cancer Plan, the Government is committing up to £10 million a year to a new fund open to al...
Answered 10 Feb 2026
Original Parliament recordProstate Cancer: AbirateroneDepartment of Health and Social CareTabled 21 Jan 2026AnsweredUIN 107546More
Question: To ask the Secretary of State for Health and Social Care, if he will make an assessment of the potential impact of Northern Ireland being the only part of the UK without routine access to abiraterone for men with non-metastatic prostate cancer on patient
Answer: There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the ...
Answered 28 Jan 2026
Original Parliament recordProstate Cancer: AbirateroneDepartment of Health and Social CareTabled 21 Jan 2026AnsweredUIN 107545More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the Northern Ireland (a) Department of Health and (b) Health and Social Care Board on levels of accessibility to abiraterone for non-metastatic prost
Answer: There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the ...
Answered 28 Jan 2026
Original Parliament recordProstate Cancer: AbirateroneDepartment of Health and Social CareTabled 21 Jan 2026AnsweredUIN 107544More
Question: To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential implications for his policies of Northern Ireland being the only part of the UK unable to offer abiraterone routinely to eligible prostate cancer patien
Answer: There are no current plans to hold discussions with the Northern Irish Department of Health or the Health and Social Care Board on abiraterone access in Northern Ireland. Decisions on the availability of medicines in Northern Ireland are a matter for the ...
Answered 28 Jan 2026
Original Parliament recordProstate Cancer: Northern IrelandDepartment of Health and Social CareTabled 16 Oct 2025AnsweredUIN 82822More
Question: To ask the Secretary of State for Health and Social Care, what discussions he has had with his counterpart in the Northern Ireland executive on the potential introduction of a national screening programme for prostate cancer.
Answer: The UK National Screening Committee (UK NSC) advises ministers and the National Health Service in the four nations of the United Kingdom about all aspects of screening. The implementation of any UK NSC screening recommendation is a devolved matter.
Answered 24 Oct 2025
Original Parliament recordBlood Cancer: DiagnosisDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 72679More
Question: To ask the Secretary of State for Health and Social Care, if he will commit to engaging with the blood cancer community to agree on an appropriate measure for early diagnosis in blood cancer.
Answer: The Department continues to support the National Health Service to diagnose and treat cancer as early and fast as possible. There have been improvements in the prognosis of blood cancer patients, with patients now living twice as long. However, we recogni...
Answered 29 Sept 2025
Original Parliament recordBlood Cancer: DiagnosisDepartment of Health and Social CareTabled 29 Aug 2025AnsweredUIN 72678More
Question: To ask the Secretary of State for Health and Social Care, what recent engagement he has had with the blood cancer community on the significance of implementing a proxy measure for early diagnosis in blood cancer.
Answer: The Department continues to support the National Health Service to diagnose and treat cancer as early and fast as possible. There have been improvements in the prognosis of blood cancer patients, with patients now living twice as long. However, we recogni...
Answered 29 Sept 2025
Original Parliament recordDoctors: RecruitmentDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67628More
Question: To ask the Secretary of State for Health and Social Care, whether his Department has had discussions with the Northern Ireland Department of Health on the (a) operation of the Foundation Programme allocation process and (b) its potential impact on applica
Answer: The UK Foundation Programme Office (UKFPO) manages the national application process for the UK Foundation Programme, issues guidance on foundation training, and promotes the consistent delivery of the Foundation Programme across the United Kingdom, includ...
Answered 21 Jul 2025
Original Parliament recordDoctors: RecruitmentDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67627More
Question: To ask the Secretary of State for Health and Social Care, whether he plans to make changes to the Foundation Programme allocation process, following the most recent application round.
Answer: NHS England is due to review the Foundation Programme allocation process. The review is aiming to commence in 2026. NHS England will advise stakeholders, including the British Medical Association, on how they can input in due course.As set out in our 10-Y...
Answered 8 Aug 2025
Original Parliament recordDoctors: RecruitmentDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67626More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to monitor the (a) fairness and (b effectiveness of the Foundation Programme allocation process.
Answer: NHS England is due to review the Foundation Programme allocation process. The review is aiming to commence in 2026. NHS England will advise stakeholders, including the British Medical Association, on how they can input in due course.As set out in our 10-Y...
Answered 8 Aug 2025
Original Parliament recordDoctors: RecruitmentDepartment of Health and Social CareTabled 14 Jul 2025AnsweredUIN 67625More
Question: To ask the Secretary of State for Health and Social Care, if his Department will support the British Medical Association's Foundation Programme Recruitment Campaign.
Answer: NHS England is due to review the Foundation Programme allocation process. The review is aiming to commence in 2026. NHS England will advise stakeholders, including the British Medical Association, on how they can input in due course.As set out in our 10-Y...
Answered 8 Aug 2025
Original Parliament recordCancer: DiagnosisDepartment of Health and Social CareTabled 10 Jul 2025AnsweredUIN 66752More
Question: To ask the Secretary of State for Health and Social Care, whether the forthcoming national cancer plan will introduce new targets for reducing late-diagnosis of cancer.
Answer: Reducing late diagnosis of cancer is a priority for the Department. As a first step, the National Health Service is now delivering an extra 40,000 operations, scans, and appointments each week, to support early diagnosis and faster treatment.NHS England i...
Answered 18 Jul 2025
Original Parliament recordDoctors: TrainingDepartment of Health and Social CareTabled 8 Jul 2025AnsweredUIN 65997More
Question: To ask the Secretary of State for Health and Social Care, whether he has taken steps following receipt of the BMA letter dated 4 April 2025 requesting review of the Foundation Programme allocations.
Answer: NHS England is due to review the Foundation Programme allocation process to make sure it works well for applicants. The review is aiming to commence in 2026. NHS England will advise stakeholders how they can input in due course.
Answered 14 Jul 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →